Mylan recalls 81,000 EpiPens over reports of device failure

Mylan (NSDQ:MYL) recalled 81,000 EpiPen emergency allergy auto-injectors this week after receiving 2 reports that the device failed to work in emergencies. The recall affects devices in Australia, New Zealand, Europe and Japan, the company reported.

Canonsburg, Penn.-based Mylan said that in both cases, patients received treatment using an alternate EpiPen. The drugmaker also said that it is working with regulatory authorities in affected countries to inform them about the recall.

Get the full story at our sister site, Drug Delivery Business News.

The post Mylan recalls 81,000 EpiPens over reports of device failure appeared first on MassDevice.

from MassDevice http://ift.tt/2o8oS9t